Home
About
FAQ
History (11)
Phosphate binder usage in kidney failure patients.
Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1.
Clues at the scene of the crime: sudden death in dialysis patients.
Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
The cardiovascular effects of erythropoietin.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The cardiovascular effects of erythropoietin.
Smith KJ, Bleyer AJ, Little WC, Sane DC. The cardiovascular effects of erythropoietin. Cardiovasc Res. 2003 Sep 01; 59(3):538-48.
View in:
PubMed
subject areas
Anemia
Cardiovascular System
Cell Division
Chromogranins
Endothelium, Vascular
Erythropoietin
GTP-Binding Protein alpha Subunits, Gs
Heart Failure
Humans
Hypertension
Kidney Failure, Chronic
Muscle, Smooth, Vascular
Myocytes, Cardiac
Nerve Tissue Proteins
Platelet Activation
Receptors, Erythropoietin
Recombinant Proteins
Thrombosis
authors with profiles
Anthony J. Bleyer MS; MD